Trump Governance Announces $13 Billion in Global Health Investments with Focus on Self-Reliance
Table of Contents
The Trump Administration has unveiled a series of landmark bilateral agreements representing over $13 billion in combined U.S. adn recipient country investment, aimed at bolstering global health systems and prioritizing American interests.These Memorandums of Understanding (MOUs), finalized within the last three months, signal a shift towards greater self-reliance for partner nations and a more focused approach to U.S. foreign assistance. “These MOUs are proof positive that president Trump’s leadership is making America safer, stronger, and more prosperous,” a senior official stated, emphasizing the strategy’s core tenets of saving lives and fostering independence.
A New Era of Bilateral Health Partnerships
Under the “America First Global Health Strategy,” launched on September 18, 2025, the United States has forged health partnerships with nine African nations: Kenya, Rwanda, Liberia, Uganda, Lesotho, Eswatini, Mozambique, Cameroon, and Nigeria. The agreements collectively represent more than $8 billion in direct U.S. investment, leveraged by over $5 billion in co-investment commitments from the recipient countries. This collaborative approach marks a departure from traditional aid models, emphasizing shared responsibility and enduring solutions.
These new MOUs are designed to maximize the impact of U.S. global health assistance by countering infectious disease threats, strengthening bilateral relationships, and building resilient health systems. The strategy aims to preserve effective U.S.assistance while addressing inefficiencies, reducing dependency, and ensuring accountability for American taxpayers.
Country-Specific Investments and commitments
Each MOU is tailored to the specific needs and priorities of the partner nation, with a focus on strengthening national ownership and capacity. Here’s a breakdown of key investments:
- Kenya: A $2.5 billion investment ($1.6 billion from the U.S., $850 million from Kenya) will support Kenya’s leadership in charting its own health priorities, shifting resources towards the national system and reducing reliance on non-governmental organizations (NGOs). The focus will be on data modernization and sustainable capacity building.
- Rwanda: With a total investment of $228 million ($158 million from the U.S., $70 million from Rwanda), the partnership aims to strengthen Rwanda’s health system, move away from NGO-led delivery, and position the nation to independently manage its HIV/AIDS response within four years. The initiative will also leverage American-made robotics, developed by Zipline International Inc., for delivering medical products and expand private sector investment in next-generation HIV treatments and artificial intelligence (AI) for healthcare.
- Liberia: A $183 million investment
The MOUs prioritize long-term sustainability through several key provisions:
- Commodity Procurement: The transition of commodity procurement from the U.S. goverment to partner governments will occur gradually throughout the MOU period. The U.S. has committed to fully funding frontline healthcare workers and commodities for the next fiscal year, working with countries to co-invest over time.
- Health Workforce Transition: Frontline health workers currently funded by the U.S. will be integrated into partner government payrolls over a multi-year period.
- Data System Enhancement: Funding will support the scaling up of partner governments’ health data systems for long-term tracking of key health metrics.
- Increased Co-Investment: Partner governments will increase their domestic health expenditures, ensuring long-term sustainability without reliance on U.S. support.
- Performance-Based Incentives: U.S.financial support will be linked to countries’ ability to meet or exceed key health metrics, incentivizing performance and accountability.
The MOUs have a maximum duration of five years and do not include any future commitment of U.S. assistance,reinforcing the “America First” approach. This strategy, according to the administration, is not only about global health but also about protecting Americans from infectious disease threats and promoting American innovation abroad.
